Moleculin Biotech, Inc. (MBRX)
7.90
-0.82
(-9.40%)
USD |
NASDAQ |
Oct 30, 16:00
8.10
+0.20
(+2.53%)
After-Hours: 20:00
Moleculin Biotech Price to Book Value : 0.242 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 0.242 |
| October 29, 2026 | 0.2672 |
| October 28, 2026 | 0.2679 |
| October 27, 2026 | 0.2839 |
| October 26, 2026 | 0.2171 |
| October 23, 2026 | 0.1991 |
| October 22, 2026 | 0.1805 |
| October 21, 2026 | 0.1933 |
| October 20, 2026 | 0.1896 |
| October 19, 2026 | 0.1624 |
| October 16, 2026 | 0.1718 |
| October 15, 2026 | 0.2268 |
| October 14, 2026 | 0.2518 |
| October 13, 2026 | 0.2667 |
| October 12, 2026 | 0.2536 |
| October 09, 2026 | 0.2708 |
| October 08, 2026 | 0.2598 |
| October 07, 2026 | 0.2689 |
| October 06, 2026 | 0.273 |
| October 05, 2026 | 0.292 |
| October 02, 2026 | 0.2983 |
| October 01, 2026 | 0.3087 |
| September 30, 2026 | 0.3066 |
| September 29, 2026 | 0.3226 |
| September 28, 2026 | 0.3487 |
| Date | Value |
|---|---|
| September 25, 2026 | 0.3686 |
| September 24, 2026 | 0.3474 |
| September 23, 2026 | 0.3235 |
| September 22, 2026 | 0.3462 |
| September 21, 2026 | 0.3188 |
| September 18, 2026 | 0.4737 |
| September 17, 2026 | 0.4779 |
| September 16, 2026 | 0.4534 |
| September 15, 2026 | 0.4605 |
| September 14, 2026 | 0.475 |
| September 11, 2026 | 0.4381 |
| September 10, 2026 | 0.5085 |
| September 09, 2026 | 0.4688 |
| September 08, 2026 | 0.4596 |
| September 04, 2026 | 0.435 |
| September 03, 2026 | 0.4139 |
| September 02, 2026 | 0.4253 |
| September 01, 2026 | 0.3983 |
| August 31, 2026 | 0.395 |
| August 28, 2026 | 0.3982 |
| August 27, 2026 | 0.422 |
| August 26, 2026 | 0.3677 |
| August 25, 2026 | 0.3744 |
| August 24, 2026 | 0.3734 |
| August 21, 2026 | 0.3634 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.712 |
| Alnylam Pharmaceuticals, Inc. | 6.129 |
| Anika Therapeutics, Inc. | 2.042 |
| Savara, Inc. | 6.891 |
| Vericel Corp. | 5.567 |
Price to Book Value Related Metrics
| Price | 7.90 |
| Earnings Yield | -4.34K% |
| Market Cap | 2.804M |